Last reviewed · How we verify
NCT04356625
Maximum Expiratory Pressure in Induced Cough as a Predictor of Extubation Failure
NA trial testing MEPic in Airway Extubation in 80 participants. Completed in 9 September 2019.
1 September 2019
Quick facts
| Lead sponsor | Hospital Nacional Profesor Alejandro Posadas |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 80 |
| Start date | 1 October 2018 |
| Primary completion | 1 September 2019 |
| Estimated completion | 9 September 2019 |
| Sites | 1 location across Argentina |
Drugs / interventions tested
- MEPic
Conditions studied
- Airway Extubation — all drugs for Airway Extubation →
Sponsor
Hospital Nacional Profesor Alejandro Posadas
Who can join
18 and older, any sex, with Airway Extubation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Clinical trial for the evaluation of diagnostic tests. The sample was composed of adults under mechanical ventilation who passed the spontaneous breathing trial and was ready to be extubated. The maximum expiratory pressure measured in the usual way and the maximum expiratory pressure generated during the induced cough were taken as predictor variables. The outcome variable was extubation failure, measured at 72 hours and at 7 days.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Maximal expiratory pressure compared with maximal expiratory pressure during induced cough as a predictor of extubation failure.
Carrera M, Urrutia JG, Ardariz CB, Porra ML, et al · · 2023 · cited 2× · PMID 37712728 · DOI 10.5935/2965-2774.20230275-en
Verify or expand the search:
- PubMed search for NCT04356625
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Airway Extubation
Currently open trials in the same condition.
- NCT05506904 — Liberation From Mechanical Ventilation Using Extubation Advisor Decision Support · NA · recruiting
Other Hospital Nacional Profesor Alejandro Posadas trials
Trials by the same sponsor.
- NCT04893928 — Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial · unknown
- NCT06727474 — Clinical and Functional Characteristics of Patients Admitted for Severe COVID-19 Pneumonia · completed
- NCT04493268 — HYPONATREMIA IN COVID-19 PATIENTS · completed
- NCT05598242 — Amniotic Membrane Treatment for Hyposecretory Dry Eye · Phase 3 · completed
- NCT03608761 — Comparison Between Rebamipide 2% Versus Autologous Serum · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04356625 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Nacional Profesor Alejandro Posadas
- Last refreshed: 4 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04356625.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing